Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype
Honda, M.; Kataoka, M.; Iima, M.; Ota, R.; Ohashi, A.; Kishimoto, A.O.; Miyake, K.K.; Nickel, M.D.; Yamada, Y.; Toi, M.; Nakamoto, Y. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography 2022, 8, 1522-1533. https://doi.org/10.3390/tomography8030125
Honda M, Kataoka M, Iima M, Ota R, Ohashi A, Kishimoto AO, Miyake KK, Nickel MD, Yamada Y, Toi M, Nakamoto Y. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype. Tomography. 2022; 8(3):1522-1533. https://doi.org/10.3390/tomography8030125
Chicago/Turabian StyleHonda, Maya, Masako Kataoka, Mami Iima, Rie Ota, Akane Ohashi, Ayami O. Kishimoto, Kanae K. Miyake, Marcel D. Nickel, Yosuke Yamada, Masakazu Toi, and Yuji Nakamoto. 2022. "Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype" Tomography 8, no. 3: 1522-1533. https://doi.org/10.3390/tomography8030125